Date of Award
9-2-2026
Thesis Type
Masters
Document Type
Thesis
Divisions
Institute for Advanced Studies
Department
Department of Biomedical Science
Institution
Universiti Malaya
Abstract
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus associated with severe neurological complications including Guillain-Barré syndrome (GBS) in adults, and microcephaly in infants. In many tropical and subtropical regions, ZIKV co-circulates with dengue virus (DENV), resulting in substantial pre-existing DENV immunity among population subsequently exposed to ZIKV. Although previous studies have investigated DENV-ZIKV cross-reactive immunity, its impact and biological outcomes remain incompletely understood, particularly in endothelial cells, which represent an important target of ZIKV infection and contribute to flavivirus pathogenesis. Therefore, the present study investigated how pre-existing DENV immunity influences the biological consequences of subsequent infection by two Asian-lineage ZIKV strains, P6-740 and PRVABC59, in human umbilical vein endothelial cells (HUVECs). The intrinsic biological characteristics of both ZIKV strains were first established by evaluating viral replication kinetics, infectious virus production, extracellular viral RNA release, and endothelial cell responses using focus-forming assay (FFA), quantitative reverse-transcription polymerase chain reaction (qRT-PCR), immunofluorescence assay and real-time cell analysis (RTCA). The influence of pre-existing DENV immunity was subsequently evaluated using DENV-immune sera with previously determined cross-neutralization titres against both ZIKV strains. Antibody-mediated effects were assessed by integrating infectious virus production, extracellular viral RNA release, and endothelial cell responses. The two ZIKV strains exhibited distinct intrinsic biological phenotypes in HUVECs. Compared with PRVABC59, P6-740 demonstrated greater infectious virus production, more pronounced replication kinetics, higher extracellular viral RNA release, and greater disruption of endothelial cell integrity. Although pre- existing DENV immunity modulated infection of both ZIKV strains, cross-neutralization titres were not consistently associated with infectious virus production, extracellular virus RNA release, or endothelial cell responses. Antibody-mediated effects differed substantially between viral strains and among individual sera. While a distinct titre dependent relationship between cross-neutralization and infectious virus production was observed for P6-740, this pattern was absent for PRVABC59. Furthermore, infectious virus production, extracellular viral RNA release, and endothelial cell responses frequently diverged following antibody exposure, demonstrating that these complementary biological parameters capture distinct aspects of antibody-mediated modulation. In conclusion, the present study demonstrates that the biological outcomes of pre-existing DENV immunity cannot be adequately predicted by cross-neutralization titres alone. Instead, antibody-mediated effects are determined by multiple factors including characteristics of the pre-existing antibody repertoire, the intrinsic biological properties of the infecting viral strains, and the biological processes being examined. These findings advance the current understanding of ZIKV-DENV cross-reactive immunity and provide a more comprehensive framework for studying how pre-existing DENV immunity shapes subsequent ZIKV infection in endothelial cells.
Additional Information
Thesis (M.A.) – Institute for Advanced Studies, Universiti Malaya, 2026.
Recommended Citation
Jo Ern, Wong, "Effects of pre-existing antibodies against dengue virus (DENV) on Zika virus (ZIKV) infection in Endhothelial cells" (2026). Student Works (2020-2029). 2066.
https://knova.um.edu.my/student_works_2020s/2066
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Initial
khm